Pancreatic Cancer section

Prostate Cancer News & Features

Galeterone active in one form of castration-resistant prostate cancer

The anticancer drug galeterone has proved successful in lowering prostate-specific antigen levels in men with castration-resistant prostate cancer (CRPC).

Not enough prostate cancer patients receive bisphosphonates

Not enough prostate cancer patients receive bisphosphonates

Men receiving hormone therapy for prostate cancer may be missing out on protective meds, researchers say.

Killing cancer by protecting normal cells

A new anticancer drug, already in clinical development, may help spare healthy cells from the effects of radiation treatments.

Personalized genetic test predicts recurrence risk for prostate cancer

A genetic test has been developed to identify which men are at higher risk for prostate cancer recurrence after localized treatment with surgery or radiotherapy.

High phosphorous intake associated with increased risk of lethal prostate cancer

High phosphorous intake associated with increased risk of lethal prostate cancer

Phosphorous is independently associated with the risk of developing lethal and high-grade prostate cancer.

Prostate Cancer Videos

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs